TBCH:NASDAQTurtle Beach Corporation Analysis
Data as of 2026-08-02 - not real-time
$12.25
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Turtle Beach trades around $12.25, sitting just above the computed support of $11.83 and below resistance near $13.40. Technicals are bearish – the 20‑day SMA (12.61) is under the 50‑day SMA (12.65), the 200‑day SMA (12.92) remains higher, RSI is neutral at 46, and the MACD histogram is negative, signalling continued downside pressure. Volatility is elevated at over 57% for the past 30 days and beta exceeds 1.6, suggesting the stock moves sharply with market swings. Fundamentals are weak: revenue fell 34% year‑over‑year, operating margins are negative, cash on hand ($12.3M) is far below total debt ($58M), and the trailing PE of 612x dwarfs the industry average of 33x. The discounted cash‑flow model caps fair value near $8.24, implying the market price is substantially overvalued, while forward earnings point to a more reasonable PE of 10.7x. The upcoming Q2 2026 earnings release on August 6 will be a critical catalyst, but the current risk profile – high volatility, bearish trend, and a substantial debt load – warrants a cautious stance. In the short term, consider holding the position and watching the earnings beat for any price bounce; over the medium horizon, remain on the sidelines pending a clear turnaround; over the long run, the valuation and financial health suggest a sell outlook.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Price near technical support with limited upside
- Upcoming Q2 earnings release
- Elevated volatility and bearish MACD
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Forward PE suggests potential earnings improvement
- Debt load remains high relative to cash
- Valuation still above DCF fair value
Long Term
> 3 yearsCautious
Model confidence: 7/10
Key Factors
- Persistent revenue decline and negative operating margins
- Severe overvaluation versus industry peers
- High beta and volatility exposing investors to large swings
Key Metrics & Analysis
Financial Health
Revenue Growth-34.00%
Profit Margin0.40%
P/E Ratio612.5
ROE1.02%
ROA2.20%
Debt/Equity51.86
P/B Ratio2.1
Op. Cash Flow$24.4M
Free Cash Flow$16.3M
Industry P/E32.8
Technical Analysis
TrendBearish
RSI46.2
Support$11.83
Resistance$13.40
MA 20$12.61
MA 50$12.65
MA 200$12.92
MACDBearish
VolumeStable
Fear & Greed Index92.88
Valuation
Fair Value$8.24
Target Price$16.40
Upside/Downside33.88%
GradeOvervalued
TypeBlend
Risk Assessment
Beta1.60
Volatility57.44%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.